1. Home
  2. Health
  3. AIDS / HIV

Pfizer Suspends HIV Drug Trial
Drug manufacturer Pfizer has halted drug trials on the promising new HIV drug capravirine. Studies have shown that very high doses of the drug causes an inflammation of blood vessels (vasculitis) in dogs. The FDA is permitting those patients currently in capravirine trials to continue the drug if they are having good viral suppression. Pfizer notes that no human has experience vasculitis resulting from taking capravirine. 

back to the news

 

 

Explore AIDS / HIV
About.com Special Features

A Balanced Life

Bring your life into balance with tips on good nutrition, family fun, and healthy activities. More >

8 Ways to Cut Drug Costs

Keep yourself, and your family, happy and healthy this season. More >

We comply with the HONcode standard for trustworthy health information: verify here.
  1. Home
  2. Health
  3. AIDS / HIV

©2010 About.com, a part of The New York Times Company.

All rights reserved.